Conference in Belgrade

The Conference entitled “Professionalism and Liberalisation in the Pharmaceutical Sector: European Experience” focused on a number of interrelated themes: negative consequences of liberalisation in the pharmaceutical sector and the announced reforms in the health care system, including pharmacies as an integral part of said.
Also discussed were experiences, implemented measures and positive outcomes in EU countries, foremost within the context of reintegration of pharmacies into the health care system and the development of pharmaceutical health care protection as an area of public interest within the Republic of Serbia.
Conclusions and Recommendations are based on debates which took place during the conference, the demonstrated experiences of European countries, and represent expert opinions, i.e. members of the Pharmaceutical Chamber of Serbia, Pharmaceutical Association of Serbia and the Association of Private Pharmacists of Serbia.
1.  Urgent adoption of the Law on the Activities of Pharmacies, which will clearly define the requirements of the pharmaceutical profession, and include: limiting founding and ownership rights of pharmacies to pharmacists, prohibition of vertical integration, the introduction of geographic and demographic criteria set for opening pharmacies. 
2. The introduction of a moratorium on the opening of pharmacies, until the adoption of the Law on the Activities of Pharmacies.
3. The introduction of unified retail costs of prescription medication, for the entire territory of the Republic of Serbia, ensuring that business conditions are equal for all providers of pharmaceutical activities, i.e. that competition is based on the quality of the service provided.
4. Urgent adoption of the Good Pharmacy Practice (GPP) document. 
5. Adoption of the Rulebook on the List of Items Allowed for Sale in Pharmacies recommended by the Working Group of the Ministry of Health, where the collective views of the profession are unified, and the withdrawal of the previously adopted Rulebook.

Copyrights © 2020 Southeast European Pharmaceutical Association